标题
A systematic review of cannabidiol dosing in clinical populations
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-06-21
DOI
10.1111/bcp.14038
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
- (2017) Evan C. Rosenberg et al. EPILEPSIA
- The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy
- (2017) Paula Province Warren et al. NEUROCASE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
- (2017) Emma H. Kaplan et al. PEDIATRIC NEUROLOGY
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
- (2016) Jacqueline S. Gofshteyn et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Cannabinoids in the management of difficult to treat pain
- (2016) Ethan Russo Therapeutics and Clinical Risk Management
- Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
- (2015) Moshe Yeshurun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report
- (2015) Dimah Saade et al. PEDIATRIC NEUROLOGY
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- The weight of nations: an estimation of adult human biomass
- (2012) Sarah Catherine Walpole et al. BMC PUBLIC HEALTH
- Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report
- (2012) J. A. S. Crippa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now